🧭 Advisory Services

We don't just connect.
We execute the deal.

BioBridge's advisory practice is the core of how we generate real business outcomes — not a side offering. Our team works directly with technology providers, corporates, and investors to validate, structure, and close cross-border technology transactions.

Explore Services ↓
This is not a self-serve marketplace. Every engagement starts with a human conversation. We curate, validate, and actively manage outcomes — that's what makes BioBridge different from a listings platform.
⚖️ What Makes Us Different

Not a marketplace.
A strategic partner.

Generic platforms list and hope. BioBridge advises, validates, and actively works the deal to close.

✕ Generic Marketplace
Passive listing & hope
  • 📄 Self-service uploads, no curation or quality control
  • 🤷 No validation of scientific or commercial readiness
  • 🔍 Search-and-browse only — no active introductions
  • 📉 No support structuring or closing the deal
  • 💸 Revenue only from subscription or listing fees
✓ BioBridge Advisory
Curated & actively managed
  • 🧪 Every technology scored on 5 readiness dimensions before activation
  • 🤝 Human-led introductions, NDA coordination, and negotiation support
  • 🌍 Regulatory & market strategy tailored to destination geography
  • 📋 Deal structuring expertise — licensing, partnership, soft landing
  • 💼 Revenue aligned with outcomes: retainers + success fees
🛠️ Our Services

Five ways we move technology to market

Each service can be engaged independently or combined into a full commercialization pathway — from first scientific assessment through closed deal.

🔭
Technology Scouting & Commercial Validation
We identify, assess, and validate the commercial potential of scientific technologies before they ever reach the network — applying the BioBridge Readiness Score™ across scientific, commercial, regulatory, scalability, and licensing dimensions.
For: ProvidersFor: Corporates seeking innovationProject-based
Deliverable: Full Readiness Score report + go-to-market recommendation
📋
Regulatory & Market Strategy
Navigating EU and LATAM regulatory pathways is one of the biggest barriers to cross-border commercialization. We map the regulatory route, identify market entry risks, and define a realistic timeline to market.
For: ProvidersFor: Seekers entering new marketsRetainer or project
Deliverable: Regulatory pathway map + market entry strategy document
🛬
Soft Landing & Internationalization
For LATAM organizations expanding into Europe (or vice versa), we coordinate the practical and strategic steps of establishing a commercial presence — partner identification, local positioning, and initial relationship building.
For: Providers expanding internationallyRetainer
Deliverable: Internationalization roadmap + introduced local contacts
📑
Licensing Strategy & Deal Structuring
We help structure licensing agreements, partnerships, and technology transfer deals that protect IP while creating fair, executable terms for both sides — drawing on patterns we've seen across the network's active pipeline.
For: Providers & SeekersSuccess-fee aligned
Deliverable: Deal structure recommendation + negotiation support
🔬
Scientific & Commercial Due Diligence
Before committing capital or signing a deal, seekers and investors need independent validation. Our advisory team conducts rigorous scientific and commercial due diligence on specific technologies or opportunities.
For: SeekersFor: InvestorsProject-based
Deliverable: Independent due diligence report with risk assessment
⚙️ Our Methodology

How an engagement unfolds

A disciplined, advisory-led process — AI accelerates discovery, but every step is validated by our team.

1
Discovery Call
We understand your technology, your goals, or your sourcing needs in a structured initial conversation — no forms, no friction.
2
Assessment & Scoring
Our team applies the BioBridge Readiness Score™ methodology, conducting structured scientific, commercial, and regulatory assessment.
3
Strategic Matching
AI-assisted matching surfaces the strongest candidates across our network; our team validates fit before any introduction is made.
4
Facilitated Introduction
We personally coordinate the first meeting, manage NDAs, and ensure both sides arrive prepared and aligned on objectives.
5
Deal Structuring & Close
We support negotiation, term structuring, and closing — staying engaged through signature, not disappearing after the introduction.
💼 Engagement Models

Flexible structures, aligned incentives

We tailor the engagement model to the stage and goals of each provider, seeker, or investor we work with.

Project-Based
Single Engagement
Best for a defined scope — a readiness assessment, due diligence report, or regulatory pathway analysis.
  • ✓ Fixed-scope deliverable
  • ✓ Defined timeline (typically 2–6 weeks)
  • ✓ One core service area
Retainer
Ongoing Advisory
Best for organizations actively scouting, expanding, or managing multiple opportunities across the network.
  • ✓ Monthly advisory hours
  • ✓ Priority access to matching & curation
  • ✓ Multi-service coverage
Success Fee
Deal-Aligned
Best for licensing, partnership, or investment transactions — we get paid when the deal closes.
  • ✓ No upfront cost in many cases
  • ✓ Fee tied to deal value on close
  • ✓ Full deal structuring support
⭐ Why Work With Us

Expertise you can't get from a database

Our advisory edge comes from combining scientific rigor, regulatory fluency, and real dealmaking experience across both continents.

🧬
Scientific Credibility
Assessment grounded in real scientific and technical evaluation, not keyword matching.
🌍
Cross-Border Fluency
Deep familiarity with both LATAM and European regulatory, cultural, and business norms.
🤝
Relationship-Driven
We maintain direct relationships with research institutions, corporates, and investors on both sides.
🎯
Outcome-Aligned
Our incentives are structured around your success — retainers plus success fees, not listing fees.
📞 Let's Talk

Ready to move your
technology or search forward?

Book a discovery call with our advisory team. No commitment — just a conversation about what's possible.

← Back to BioBridge Home

© 2025 BioBridge Technology Access Network · advisory@biobridge.network